Publications of Angelika Erhardt
All genres
Journal Article (83)
2007
Journal Article
41, doi:10.1016/j.jpsychires.2006.06.001, pp. 579 - 584 (2007)
Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. Journal of Psychiatric Research 2006
Journal Article
31 (12), pp. 2573 - 2579 (2006)
Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: Novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology
Journal Article
141B (7), pp. 739 - 740 (2006)
An association candidate-gene study on genetic variations within HTR2A in patients suffering from panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Journal Article
5 (10), pp. 1914 - 1920 (2006)
Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics
Journal Article
59 (8 Suppl. S), p. 200S - 200S (2006)
Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Biological Psychiatry
Journal Article
16 (Suppl. 1), p. S88 - S88 (2006)
Possible genetic implications of the endo-cannabinoid system in anxiety disorders versus depressive disorders. European Neuropsychopharmacology
Journal Article
31, pp. 2515 - 2522 (2006)
Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 2005
Journal Article
138B (1), p. 44 - 44 (2005)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Journal Article
138B (1), p. 45 - 45 (2005)
Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Journal Article
38 (5), p. 240 - 240 (2005)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry
Journal Article
38 (5), p. 240 - 240 (2005)
Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with agoraphobia and panic attacks. Pharmacopsychiatry
Journal Article
38 (5), p. 282 - 282 (2005)
Polymorphisms in the serotonin receptor gene HTR2A modulate disease severity and susceptibility for anxiety disorders but not depression and are associated with specific personality traits. Pharmacopsychiatry
Journal Article
38 (5), p. 284 - 284 (2005)
The explorative-reduced (EXR002) C3H mice - a new mouse model of depression? Pharmacopsychiatry 2004
Journal Article
29 (11), pp. 2074 - 2080 (2004)
Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology
Journal Article
130B (1), p. 66 - 66 (2004)
Possible association of oxytocin and prolactin polymorphisms with panic and anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Journal Article
130B (1), pp. 64 - 65 (2004)
Interactions of polymorphisms in corticotropin releasing hormone receptor 1 (CRHR1) and vasopressin receptor 1B (V1B) genes predispose for panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Journal Article
130B (1), pp. 66 - 67 (2004)
Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
Journal Article
130B (1), pp. 67 - 68 (2004)
Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 2003
Journal Article
36 (5), p. 223 - 223 (2003)
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice - influence of CRH1-receptor antagonism. Pharmacopsychiatry
Journal Article
36 (5), pp. 223 - 224 (2003)
Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal. Pharmacopsychiatry